Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 5.81
-0.684 %
$ 334 M
Market Cap
21.52
P/E
CASH FLOW STATEMENT
4.38 M
OPERATING CASH FLOW
-5.84 M
INVESTING CASH FLOW
22.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Kamada Ltd.
| Net Income | 8.41 M |
| Depreciation & Amortization | 12.9 M |
| Capital Expenditures | -5.94 M |
| Stock-Based Compensation | 1.31 M |
| Change in Working Capital | -18.5 M |
| Others | 3.84 M |
| Free Cash Flow | -1.56 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||
| Net Income | 8.4 | (2.3) | (2.2) | 17.1 | 22.3 | 22.3 | 6.9 | (6.7) | (11.3) | (12.6) | 0.4 | 0.3 | (3.5) | (15.2) | (22.0) | (12.4) | (22.9) |
| Depreciation & Amortization | 12.9 | 12.2 | 5.6 | 4.9 | 4.5 | 3.7 | 3.5 | 3.5 | 3.2 | 2.8 | 3.0 | 3.0 | 2.9 | 2.8 | 2.5 | 2.4 | 2.1 |
| Deferred Income Tax | 0.1 | 62 K | 0.3 | 1.4 | 0.7 | (2.0) | 0.3 | 1.7 | 0.7 | 52 K | 24 K | 0.5 | (2.0) | (1.8) | (2.6) | (1.5) | (0.3) |
| Stock Based Compensation | 1.3 | 1.2 | 0.5 | 1.0 | 1.2 | 0.9 | 0.5 | 1.1 | 1.9 | 3.8 | 1.3 | 1.3 | 1.0 | 1.8 | 1.7 | 0.3 | 0.2 |
| Other Operating Activities | 86.9 K | 5.9 | 1.3 | 1.8 | 0.6 | (0.4) | 0.7 | (1.6) | (0.2) | 1.0 | 2.1 | 0.9 | 1.2 | 4.4 | 5.7 | (4.6) | 6.6 |
| Change in Working Capital | (18.5) | 11.6 | (14.4) | (7.1) | (1.7) | (14.1) | (7.9) | 3.9 | (8.4) | (4.9) | (10.7) | (14.3) | 1.4 | 18.6 | 1.7 | 3.1 | 1.7 |
| Cash From Operations | 4.4 | 28.6 | (8.8) | 19.1 | 27.6 | 10.5 | 3.9 | 1.9 | (14.0) | (9.9) | (3.9) | (8.3) | 0.9 | 10.6 | (13.1) | (12.7) | (12.6) |
| INVESTING CASH FLOW | |||||||||||||||||
| Capital Expenditures | (5.9) | (3.8) | (3.7) | (5.5) | (2.3) | (2.9) | (4.4) | (2.6) | (2.7) | (3.1) | (5.6) | (4.6) | (1.9) | (3.8) | (5.3) | (3.7) | (7.6) |
| Other Items | 98.9 K | 0 | (57.3) | (7.6) | 1.7 | (2.3) | (11.4) | 4.3 | 14.0 | (23.7) | 1.7 | 2.2 | 0.8 | (19.5) | (0.5) | 0.1 | 0.5 |
| Cash From Investing Activities | (5.8) | (3.8) | (61.0) | (13.1) | (0.6) | (5.2) | (15.9) | 1.6 | 11.3 | (26.8) | (3.9) | (2.4) | (1.1) | (23.3) | (5.8) | (3.6) | (7.1) |
| FINANCING CASH FLOW | |||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (18.3) | (3.7) | 18.6 | (1.6) | (1.5) | (0.6) | (0.3) | 1.5 | (7.6) | (7.7) | (4.3) | 12 K | (0.8) | 68.3 K | 4.0 | 12.1 | 4.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (16.4) | (5.6) | 19 K | 64 K | 16 K | 9 K | 3 K | 0 | 1.3 | 88 K | 0.6 | 3.0 | 0.4 | 7.6 | 2.3 | 13.1 | 10.3 |
| Cash From Financing Activities | 22.7 | (9.3) | 18.6 | 23.4 | (1.5) | (0.6) | 15.3 | 1.5 | (6.4) | (7.6) | 49.2 | 3.0 | (0.4) | 7.6 | 36.0 | 25.2 | 14.3 |
| CHANGE IN CASH | |||||||||||||||||
| Net Change In Cash | 20.8 | 15.7 | (51.3) | 27.5 | 24.6 | 5.4 | 2.7 | 4.9 | (9.5) | (44.6) | 42.2 | (7.5) | 0.5 | (6.7) | 17.1 | 9.3 | (5.5) |
| FREE CASH FLOW | |||||||||||||||||
| Free Cash Flow | (1.6) | 24.8 | (12.5) | 13.6 | 25.3 | 7.7 | (0.6) | (0.7) | (16.7) | (13.0) | (9.5) | (12.9) | (0.9) | 6.8 | (18.4) | (16.4) | (20.2) |